{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:04:20Z","timestamp":1780355060988,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ajog.2017.05.022","type":"journal-article","created":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T22:46:13Z","timestamp":1494974773000},"page":"371.e1-371.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth"],"prefix":"10.1016","volume":"217","author":[{"given":"Angela","family":"Ning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J.","family":"Vladutiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Dotters-Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Goodnight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy A.","family":"Manuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2017.05.022_bib1","first-page":"1","article-title":"Births in the United States, 2015","author":"Martin","year":"2016","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.ajog.2017.05.022_bib2","first-page":"1","article-title":"Births: final data for 2015","volume":"66","author":"Martin","year":"2017","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ajog.2017.05.022_bib3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2006-2386","article-title":"Cost of hospitalization for preterm and low birth weight infants in the United States","volume":"120","author":"Russell","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2017.05.022_bib4","doi-asserted-by":"crossref","first-page":"103.e1","DOI":"10.1016\/j.ajog.2016.01.004","article-title":"Preterm neonatal morbidity and mortality by gestational age: a contemporary cohort","volume":"215","author":"Manuck","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.022_bib5","doi-asserted-by":"crossref","first-page":"426.e1","DOI":"10.1016\/j.ajog.2014.01.046","article-title":"Correlation between initial neonatal and early childhood outcomes following preterm birth","volume":"210","author":"Manuck","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.022_bib6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-0035-1571150","article-title":"Short- and long-term outcomes of moderate and late preterm infants","volume":"33","author":"Natarajan","year":"2016","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2017.05.022_bib7","doi-asserted-by":"crossref","first-page":"e1014","DOI":"10.1542\/peds.2007-2976","article-title":"Impact of intensive care practices on short-term and long-term outcomes for extremely preterm infants: comparison between the British Isles and France","volume":"122","author":"Bodeau-Livinec","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2017.05.022_bib8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.clp.2013.07.006","article-title":"Long-term outcomes of moderately preterm, late preterm, and early term infants","volume":"40","author":"Vohr","year":"2013","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.ajog.2017.05.022_bib9","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.283.12.1591","article-title":"Rates of and factors associated with recurrence of preterm delivery","volume":"283","author":"Adams","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2017.05.022_bib10","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/1471-0528.12182","article-title":"Risk factors for recurrent preterm birth in multiparous Utah women: a historical cohort study","volume":"120","author":"Simonsen","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2017.05.022_bib11","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/aogs.13027","article-title":"Recurrence of second trimester miscarriage and extreme preterm delivery at 16\u201327 weeks of gestation with a focus on cervical insufficiency and prophylactic cerclage","volume":"95","author":"Sneider","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2017.05.022_bib12","doi-asserted-by":"crossref","first-page":"576.e1","DOI":"10.1016\/j.ajog.2007.01.039","article-title":"Recurrence risk for preterm delivery","volume":"196","author":"McManemy","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.022_bib13","first-page":"379","article-title":"Recurrence of preterm birth in singleton and twin pregnancies","volume":"98","author":"Bloom","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.022_bib14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/AOG.0b013e318184181a","article-title":"Estimating recurrence of spontaneous preterm delivery","volume":"112","author":"Esplin","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.022_bib15","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/AOG.0000000000001682","article-title":"Pregnancy outcomes in women with a history of previable, preterm prelabor rupture of membranes","volume":"128","author":"Monson","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.022_bib16","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.05.022_bib17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.AOG.0000275287.08520.4a","article-title":"Prediction and prevention of recurrent spontaneous preterm birth","volume":"110","author":"Spong","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.022_bib18","doi-asserted-by":"crossref","first-page":"622.e1","DOI":"10.1016\/j.ajog.2016.07.013","article-title":"Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system","volume":"215","author":"Manuck","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.022_bib19","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/AOG.0b013e3182723b1b","article-title":"Prediction and prevention of preterm birth. ACOG Practice bulletin no. 130","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.022_bib20","doi-asserted-by":"crossref","first-page":"B11","DOI":"10.1016\/j.ajog.2017.01.022","article-title":"The choice of progestogen for the prevention of preterm birth in women with singleton pregnancy and prior preterm birth","volume":"216","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.022_bib21","first-page":"46","article-title":"Impact of 17P usage on NICU admissions in a managed medicaid population\u2014a five-year review","volume":"19","author":"Mason","year":"2010","journal-title":"Manag Care"},{"key":"10.1016\/j.ajog.2017.05.022_bib22","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJM200002243420802","article-title":"Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"342","author":"Carey","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.05.022_bib23","doi-asserted-by":"crossref","first-page":"260.e1","DOI":"10.1016\/j.ajog.2007.07.013","article-title":"Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter?","volume":"197","author":"How","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.022_bib24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/14767050601152845","article-title":"Gestational age at initiation of 17-hydroxyprogesterone caproate (17P) and recurrent preterm delivery","volume":"20","author":"Gonzalez-Quintero","year":"2007","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2017.05.022_bib25","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0002-9378(93)90087-Y","article-title":"Multicenter randomized, controlled trial of a preterm birth prevention program. Collaborative Group on Preterm Birth Prevention","volume":"169","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.022_bib26","first-page":"54","article-title":"The West Los Angeles Preterm Birth Prevention Project. I. Program impact on high-risk women","volume":"170","author":"Hobel","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.022_bib27","doi-asserted-by":"crossref","first-page":"320.e1","DOI":"10.1016\/j.ajog.2011.01.011","article-title":"Pregnancy outcomes in a recurrent preterm birth prevention clinic","volume":"204","author":"Manuck","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.022_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/AOG.0000000000000048","article-title":"Preterm birth rates in a prematurity prevention clinic after adoption of progestin prophylaxis","volume":"123","author":"Markham","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.05.022_bib29","doi-asserted-by":"crossref","first-page":"128.e1","DOI":"10.1016\/j.ajog.2013.10.008","article-title":"Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth","volume":"210","author":"Caritis","year":"2014","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817306312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817306312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:17:24Z","timestamp":1757589444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937817306312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0002937817306312"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2017.05.022","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2017.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}